Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome
Phase 4
- Conditions
- Metabolic Syndrome
- Interventions
- Registration Number
- NCT02940366
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
This purpose of this study is to evaluate effect of high-dose Pitavastatin on glucose control in patients with metabolic syndrome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Patients diagnosed as metabolic syndrome according to National cholesterol Education Program criteria
- Patients with hypercholesterolemia who required to start statin therapy
Exclusion Criteria
- overt diabetes
- acute coronary syndrome within 2 months
- acute cerebrovascular event within 2 months
- recent treatment of statin within 1month
- recent diagnosed neoplasm
- recent diagnosed liver disease
- chronic kidney disease
- patients with myopathy
- pregnant women, nursing mothers, women with possibility of pregnant
- patients being adminstered cyclosporine
- patients with genetic disease such as galactose intolerance, lactose intolerance, glucose-galactose malabsorption
- patients with treatment cyclosporin
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pitavastatin 4 mg orally daily Pitavastatin 4 mg orally daily - Atorvastatin 20 mg orally daily Atorvastatin 20 mg orally daily -
- Primary Outcome Measures
Name Time Method Absolute change in HbA1c level baselina and after 24months treatment
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of